ImmuneOnco Biopharmaceuticals (Shanghai) Receives $5 Million in Near-Term Payment ImmuneOnco Biopharmaceuticals (Shanghai) (HKG:1541) received a near-term payment from SynBioTx under the license and ...
Source LinkImmuneOnco Biopharmaceuticals (Shanghai) Receives $5 Million in Near-Term Payment ImmuneOnco Biopharmaceuticals (Shanghai) (HKG:1541) received a near-term payment from SynBioTx under the license and ...
Source Link
Comments